Telix Pharmaceuticals | TLX - Nettoeinkommen

Aktienkurs
12.50
Täglich Wechseln
-0.30 -2.34%
Monatlich
35.87%
Jährlich
-56.79%
Q1 Prognose
12.48




Nettoeinkommen Veränderung Datum
Cochlear AUD 161.5M 69.6M 2025-12
CSL USD 401M 96.5M 2025-12
Integral Diagnostics AUD 6.06M 72.81M 2024-06
Mayne Pharma AUD -103.68M 68.4M 2024-06
Medical Developments International AUD -226K 121K 2025-12
Mesoblast USD -40.16M 14.05M 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Pacific Edge NZD -19.12M 3.68M 2025-12
Paradigm Biopharmaceuticals AUD -23.24M 16.82M 2025-12
Polynovo AUD 3K 9.87M 2025-12
PYC Therapeutics AUD -22.83M 10.46M 2025-12
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 392.59M 44.05M 2025-12
Sonic Healthcare AUD 236.68M 82.29M 2024-12